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Figure S1- Related to Figure 1. 
(A) Growth assays of the yeast strains used in purification of the DH Mcm2-7 complexes. 5-fold serial 
dilution of log phase cells were spotted on the plates and incubated for 3 days at the indicated 
temperatures before being photographed.  
(B) Mcm10 shows positive interactions with Mcm2, 4, 6 and 7 in a yeast two-hybrid assay (Y2H). 
MCM2-7 were cloned into pGADT7 and introduced to AH109 strain in the presence or absence of 
a pBGKT7 plasmid expressing the indicated Mcm10 alleles. Yeast two hybrids were carried out as 
in Table S1.  
Figure S2. 
 
Figure S2- Related to Figure 2.  
(A) Growth assays of the yeast strains used in the MCM DH splitting assay. Introduction of a second 
copy of MCM2 with GFP tag does not interfere with normal cell growth.  
(B) The growth of the Mcm10 depletion strains transformed with an empty vector or wild type MCM10 
was examined by spotting on the indicated media at either 25°C or 37°C. See Figure 2C for Mcm10 
depletion.  
(C) Raw quantification data of in vivo MCM DH split assay shown in Figure 2E. To ensure the signals 
are within the linear range, immunoblots with different exposure were quantified by Quantity One 
(Biorad) as indicated on the films. 
Figure S3. 
 
Figure S3- Related to Figure 3. Mcm10 is able to directly bind the N-termini of Mcm2, 4, and 6, 
which associate each other at the interface of MCM DH in vitro. 
(A, B) Similar to Mcm2 full length (A), Mcm2N (a.a. 1-390) (B) showed robust interaction with full 
length and truncations of Mcm10 in a yeast two-hybrid assay (Y2H).  
Full-length of MCM2 (A) or its N-terminal fragment (B) was cloned into pGADT7 and introduced to 
AH109 strain in the presence or absence of a pBGKT7 plasmid expressing the indicated Mcm10 alleles. 
Yeast two hybrids were carried out as in Table S1.
Figure S4. 
 
Figure S4- Related to Figure 4.  
Cell cycle profiles of the samples used for coimmunoprecipitation experiments of native chromatin 
fractions in Figure 4. 
Cells were synchronized by addition of 7.5 μg/ml of α factor. G1 arrested cells were released by filter 
washing twice in fresh SC-His medium and continued growth for the indicated time. 
Figure S5 
 
Figure S5- Related to Figure 6.  
(A) Representative cell cycle profiles of the cell samples used for double hexamer splitting assay in 
Figure 6. Cells were collected at the indicated time after released from G1 arrest. Cell cycle profiles 
were analyzed by flow cytometry. 
(B) Raw quantification data of in vivo MCM DH split assay shown in Figure 6B. To ensure the signals 
are within the linear range, immunoblots with different exposure were quantified by Quantity One 
(Biorad) as indicated on the films. 
Table S1. Mcm10 was identified as an interactor of several Mcm2-7 subunits in yeast two-hybrid. 
Related to Figure 1.  
AD BD Y2H 
interaction* 
MCM2 empty - 
MCM3 empty - 
MCM4 empty - 
MCM5 empty - 
MCM6 empty - 
MCM7 empty - 
empty MCM10 - 
MCM2 MCM10 ++++ 
MCM2(1-390) MCM10 ++++ 
MCM2 MCM10(1-463) ++++ 
MCM3 MCM10 - 
MCM4 MCM10 + 
MCM4 (1-400) MCM10 + 
MCM5 MCM10 +/- 
MCM6 MCM10 +++ 
MCM7 MCM10 ++ 
* Y2H interaction: “++++” represents growing on SC-L-W-H-A; “+++” represents growing on 
SC-L-W-H plus 10 mM 3AT; “++” represents growing on SC-L-W-H; “+” or “+/-” represents growing 
relatively weak on SC-L-W-H. 
Table S2. Strains used in this study-Related to Experimental Procedures. 
Strain Genotype Source 
BY4741 MATahis3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Gift from Dr. 
Junbiao Dai 
BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Gift from Dr. 
Junbiao Dai 
W303-1a MATa trp1-1 ura3-1 his3-11,15 leu2-3,112 ade2-1 can1-100 
RAD5 
Gift from Dr. Judith 
L. Campbell 
AH109 MATa trp1-901 leu2-3,112 ura3-53 his3-200 gal4Δ 
gal80ΔLYS2::GAL1UAS-GAL1TATA-HIS3 
GAL2UAS-GAL1TATA-ADE2 URA3::MEL1UAS-MEL1TATA-lacZ 
MEL1 
Clontech 
Y187 MATα ura3-52 his3-200 ade2-101 trp1-901 leu2-3 112 gal4Δ 
met– gal80Δ URA3::GAL1UAS-GAL1TATA-lacZ 
Clontech 
QY310 W303 MATa HIS3::MCM2-3HA This study 
QY317 W303 MATa KanMX6::MCM10-5FLAG This study 
QY336 W303 HIS3::MCM2-3HA KanMX6::MCM10-5FLAG This study 
QY606 BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 lys2Δ0 
mcm10Δ::KanMX6 pMCM10/URA3 
This study 
QY713 BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 lys2Δ0 
mcm10Δ::KanMX6 pMCM10/URA3 LEU2::MCM2-GFP 
This study 
QY715 BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 lys2Δ0 
mcm10Δ::KanMX6 pMCM10/URA3 LEU2::MCM4-GFP 
This study 
QY793 BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 lys2Δ0 
mcm10Δ::KanMX6 pMCM10/URA3 LEU2::MCM4-5FLAG 
This study 
QY6129 BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 lys2Δ0 
mcm10Δ::KanMX6 pMCM10/HIS3 LEU2::MCM4-5FLAG 
NatMX::CDC45-3HA 
This study 
QY6131 BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 lys2Δ0 
mcm10Δ::KanMX6 pmcm10ΔC/HIS3 LEU2::MCM4-5FLAG 
NatMX::CDC45-3HA 
This study 
QY6141 BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 lys2Δ0 
mcm10Δ::KanMX6 pMCM10/HIS3 LEU2::MCM4-5FLAG 
NatMX::CDC45-3HA (p317MCM2-GFP::LYS2) 
This study 
QY6142 BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 lys2Δ0 
mcm10Δ::KanMX6 pmcm10ΔC/HIS3 LEU2::MCM4-5FLAG 
NatMX::CDC45-3HA (p317MCM2-GFP::LYS2) 
This study 
QY394 BY4741 KanMX::td-mcm10(1-463)-aid 
ubr1::PGAL1-UBR1-PGAL1-OsTIR1-9MYC-URA3 
This study 
 
Table S3. Plasmids used in this study- Related to Experimental Procedures. 
Plasmid Base plasmid/Genotype Source 
pET28a-MCM2 kan 
r
6His- MCM2 This study 
pET28a-mcm2(1-299) kan
r 
6His- mcm2 (1-299) This study 
pET28a-MCM10 kan
r 
6His- MCM10 This study 
pGEX-4T-1-MCM10 amp
r
 GST- MCM10 This study 
pGEX-4T-1-mcm10(1-128) amp
r
 GST- mcm10 (1-128)  This study 
pGEX-4T-1-mcm10(1-463) amp
r
 GST- mcm10 (1-463) This study 
pGEX-4T-1-mcm6(1-439) amp
r
 GST- mcm6 (1-439) This study 
pGEX-4T-1-mcm4(1-471) amp
r
 GST- mcm4 (1-471) This study 
pGEX-4T-1-mcm10(464-571) amp
r
 GST- mcm10 (464-571) This study 
pGEX-6P-1-MCM10 amp
r
 GST- MCM10 This study 
pRS313-MCM10-5FLAG amp
r
/HIS3 MCM10-5FLAG This study 
pRS313-mcm10 ΔN ampr/HIS3 mcm10 Δ(1-128) -5FLAG This study 
pRS313-mcm10 ΔC ampr/HIS3 mcm10 Δ(464-571) -5FLAG This study 
pRS313-MCM10-GBP amp
r
/HIS3 MCM10-GBP This study 
pRS313- mcm10 ΔC -GBP ampr/HIS3 mcm10 Δ(464-571)-GBP This study 
pRS317-MCM2-GFP amp
r
/LYS2 MCM2-GFP This study 
pGADT7-MCM2 amp
r
/LEU2 GAL4-AD-MCM2 This study 
pGADT7-MCM3 amp
r
/LEU2 GAL4-AD-MCM3 This study 
pGADT7-MCM4 amp
r
/LEU2 GAL4-AD-MCM4 This study 
pGADT7-MCM5 amp
r
/LEU2 GAL4-AD-MCM5 This study 
pGADT7-MCM6 amp
r
/LEU2 GAL4-AD-MCM6 This study 
pGADT7-MCM7 amp
r
/LEU2 GAL4-AD-MCM7 This study 
pGADT7-mcm2N amp
r
/LEU2 GAL4-AD-mcm2(1-390) This study 
pGADT7-mcm4N amp
r
/LEU2 GAL4-AD-mcm4(1-400) This study 
pGBKT7-MCM10 kan
r
/TRP1GAL4-BD-MCM10 This study 
pGBKT7- mcm10 (1-128) kan
r
/TRP1GAL4-BD-mcm10 (1-128) This study 
pGBKT7- mcm10 (1-463) kan
r
/TRP1GAL4-BD-mcm10 (1-463) This study 
pGBKT7- mcm10 (129-571) kan
r
/TRP1GAL4-BD-mcm10 (129-571) This study 
pGBKT7- mcm10 (129-463) kan
r
/TRP1GAL4-BD-mcm10 (129-463) This study 
pGBKT7- mcm10 (464-571) kan
r
/TRP1GAL4-BD-mcm10 (464-571) This study 
  
Supplemental Experimental Procedures 
Strains and plasmids 
Strains and plasmids used in this study are listed in Supplemental Table S2-S3. Mutants were generated 
using recombination-mediated cassette exchange (Longtine et al., 1998) or tetrad dissection as 
previously described (Lou et al., 2008). All constructs were confirmed by DNA sequencing. 
Cell synchronization and flow cytometry analysis 
7.5 μg/ml of α factor was added for cell synchronization in G1-phase. G1 arrested cells were released 
by filter washing twice in fresh medium and continued growth for the indicated time. Samples were 
collected and fixed with 70% ethanol and then processed for flow cytometry using a BD Biosciences 
FACSVerse machine. 
Whole cell extracts (WCE) and immunoblotting (IB) 
WCE of one hundred OD600 units of asynchronized or synchronized cells were prepared by glass bead 
beating (Mini-Beadbeater-16, Biospec,USA) in lysis buffer {45 mM HEPES, pH 7.2, 150 mM NaCl, 1 
mM EDTA, 10% glycerol, 0.2% NP-40, 1 mM PMSF, 2 mM DTT, 1× Protease Inhibitor Cocktail 
tablet (Roche), 1× PhosSTOP tablet (Roche)}. Protein fractions were separated by SDS polyacrylamide 
gel electrophoresis (PAGE) and transferred to PVDF membrane. Each protein was probed with the 
antibody specifically indicated in each figure by western blotting. Antibodies used in this study are: 
anti-Cdc45 (gift from Dr. Karim Labib); mouse anti-FLAG M2-specific monoclonal antibody (1:2000, 
Sigma), mouse anti-HA 16B12 (1:1000, Millipore). polyclonal anti-GST (glutathione transferase) 
(1:1000,ORIGENE ), anti-6His antibodies (1:1000, ORIGENE); anti-tubulin(1:10000, MBL) ; 
Anti-Rad53 (1:1000, Abcam); protein-G-agarose (GE Healthcare), NHS-activated agarose resins (GE 
Healthcare). HRP-conjugated anti-rabbit or anti-mouse IgG was used as the secondary antibody (1:10 
000, Sigma).  
Immunoprecipitation (IP) 
IP analysis was performed using strains co-expressing the tagged versions of each protein at 
physiological level as indicated in each figure. IP was carried out basically as described previously 
(Lou et al., 2008). Input (IN) corresponding to approximately 100 μg total protein, were analyzed in 
parallel with immunoprecipitates (IP). Proteins were analyzed by mass spectrometry or western 
blotting using indicated antibodies. 
Large scale native chromatin fractionation 
The large scale native chromatin fraction was prepared essentially as described (Liang and Stillman, 
1997; Sheu and Stillman, 2006) with minor modifications. Briefly, cells (strains QY6129, QY6131) of 
150 OD600 units were spheroplasted by incubation with 50 U/ml lyticase (Sigma). Crude extract was 
prepared by Triton X-100 treatment and fractionized via sucrose cushion in 500 μl of the modified 
EBX-1 buffer {50 mM HEPES/KOH pH7.5, 150 mM KGlu, 2.5 mM MgOAc, 0.1 mM ZnOAc, 2 mM 
NaF, 0.5 mM spermidine, 20 mM -Glycerophosphate, 3 mM ATP, 1 mM DTT, 1 mM PMSF, Protease 
inhibitor tablets (EDTA free, Roche)}. The supernatant (SN1) contains non-chromatin bound proteins, 
while the chromatin is in the pellet. Chromatin-bound proteins (SN2) were released by rotation the 
pellet with EBX-1 buffer supplemented with 200 U/ml of Benzonase (Sigma) and 3 mM ATP for 30 
min at 4°C. 
For Cdc45-IP and Mcm10-IP, 500 μl of SN2 was mixed with α-HA (Roche) or purified polyclonal 
antibody against Mcm10 for 1h on ice. Protein G Sepharose was added and incubation continued for 2h 
with rotation at 4°C. Nonspecific binding proteins were washed out by 1 ml EBX-1 buffer 
supplemented with 3 mM ATP for three times. The precipitated fraction was analyzed by 8% 
SDS-PAGE and immunoblots with indicated antibodies. 
Sucrose gradient centrifugation 
Two litres of G1 or S phase yeast cells (4×10
7 
cells/ml) were fractionated as illustrated in Figure 1A by 
using the EBX-3 buffer {50 mM HEPES/KOH pH7.5, 150 mM KGlu, 2.5 mM MgOAc, 0.1 mM 
ZnOAc, 2 mM NaF, 0.5 mM spermidine, 20 mM -Glycerophosphate, 3 mM ATP, 1 mM DTT, 1 
mM PMSF, Protease inhibitor tablets (EDTA free, Roche)}. 10 ml of SN1 or SN2 was mixed with 250 
μl M2 beads for 3h with rotation at 4°C, and washed three times with 5 ml EBX-3 buffer. The bound 
fraction was eluted 300 μl of 2 μg/μl FLAG peptide. The 600 μl SN1 or SN2 FLAG elution was 
applied to a 5-30% sucrose gradient in buffer EBX-3. The samples were then centrifuged at 100,000g 
for 5 h in a SW55 Ti rotor (Beckman Coulter). After centrifugation, the fractions (400 μl each) were 
collected from the top of the gradient and subjected to SDS-PAGE and immunoblots. Aldlase (158 kDa) 
and thyroglobulin (669 kDa) were used as size makers.  
Protein expression, purification 
Full length and truncated forms of pGEX4T-1-MCM10, pGEX-4T-1-mcm6(1-439), 
pGEX-4T-1-mcm4(1-471), pET28a-MCM10, pET28a-MCM2, pET28a-mcm2(1-299) constructs used 
in the biochemical experiments were expressed in E. coli BL21 (DE3) RIL codon-plus (Stratagene) and 
purified by affinity tags and conventional column chromatography. 
Preparation of antibodies and Mcm10 agarose beads 
To raise polyclonal antibody specific to Mcm10 or Mcm2, purified full-length protein was used to 
immunize rabbits. Polyclonal antibodies were affinity purified. Mcm10 beads were prepared by 
immobilize purified Mcm10 protein to NHS-activated agarose beads as recommended by the 
manufacturer (GE Healthcare), which was used for efficient in vitro pull-down assay. 
In vitro pull-down assay 
Approximately ten picomoles of each protein were mixed with glutathione-Sepharose 4B (GE 
Healthcare Life Sciences) or anti-Mcm10 agarosebeads made in this study were mixed in 100 μl of 
binding buffer (50 mM HEPES-NaOH pH 7.6, 150 mM NaCl, 10% glycerol, 1 mM EDTA, 1 mM 
PMSF, 1 μg/μl BSA, and 0.1% Triton X-100) and incubated for 1 h at 4°C. The beads were washed at 
least three times prior to Western blotting and/or Coomassie staining. 
Construction of mcm10 alleles 
Viability of various mcm10 alleles was determined by plasmid shuffling since MCM10 is an essential 
gene. Wild type MCM10 was cloned and expressed in pRS316/URA3 vector to allow mcm10Δ mutants 
grow. pRS316-MCM10 plasmid was removed on 5-FOA plates due to its expression of URA3, which 
caused cells toxic to 5-FOA. The ability to support cell growth was tested for various mcm10 alleles 
expressed in pRS313/HIS3 vector under a range of genetic background as indicated in each figure. 
5-fold serial dilution of log phase cells were spotted on SC-His plates in the presence or absence of 
5-FOA and incubated for 2 days at indicated temperature before photographed. 
In vivo GFP trap assay (protein tethering assay) 
Interaction between mcm10 mutants and Mcm2-7 was restored through a tethering strategy using the in 
vivo GFP trap (Qu et al., 2013). In Mcm10-Mcm2-7 tethering experiments, each mcm10 allele was 
fused to GBP (GFP binding protein), while the Mcm2 or Mcm4 subunit was tagged with GFP. To 
ensure specific targeted protein tethering, omission of one of the GFP/GBP pairs was included in all 
tethering assays as controls.  
Yeast two-hybrid assays 
Yeast two-hybrid assays with full-length of each subunit of Mcm2-7 constructed in pGADT7 and 
Mcm10 in pGBKT7 were basically performed as described previously (Lou et al., 2008). A pair of 
pGBKT7 and pGADT7 derivatives was introduced into Saccharomyces cerevisiae AH109 and Y187 
cells, respectively. Transformants harboring either pGBKT7 or pGADT7 constructs were selected on 
synthetic growth medium lacking tryptophan (SC-W) or leucine (SC–L), respectively. The interaction 
was analyzed by growing on select media lacking histidine (–LWH) or histidine and adenine (–LWHA) 
at 30°C for 2–3 days. 
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